PP
EPZM

PDT Partners’s Epizyme, Inc EPZM Stock Holding History

PDT Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31,115
Closed -$78K – 1178
2021
Q4 		$78K Buy
+31,115
New +$122K 0.01% 834
2021
Q3 		– Sell
-141,752
Closed -$1.18M – 967
2021
Q2 		$1.18M Buy
141,752
+45,376
+47% +$383K 0.08% 347
2021
Q1 		$839K Sell
96,376
-79,881
-45% -$827K 0.06% 400
2020
Q4 		$1.91M Buy
176,257
+29,795
+20% +$368K 0.13% 251
2020
Q3 		$1.75M Sell
146,462
-13,654
-9% -$183K 0.12% 226
2020
Q2 		$2.57M Buy
160,116
+50,664
+46% +$884K 0.17% 185
2020
Q1 		$1.7M Buy
109,452
+24,900
+29% +$535K 0.13% 171
2019
Q4 		$2.08M Sell
84,552
-69,643
-45% -$1.03M 0.13% 192
2019
Q3 		$1.59M Sell
154,195
-39,477
-20% -$498K 0.09% 229
2019
Q2 		$2.43M Buy
193,672
+41,372
+27% +$532K 0.14% 166
2019
Q1 		$1.89M Sell
152,300
-72
-0% -$805 0.11% 207
2018
Q4 		$939K Buy
152,372
+26,783
+21% +$205K 0.05% 274
2018
Q3 		$1.33M Sell
125,589
-31,111
-20% -$355K 0.06% 277
2018
Q2 		$2.12M Sell
156,700
-343
-0.2% -$5.34K 0.08% 250
2018
Q1 		$2.79M Buy
157,043
+343
+0.2% +$5.79K 0.09% 233
2017
Q4 		$1.97M Buy
+156,700
New +$2.28M 0.06% 303
2017
Q1 		– Sell
-54,600
Closed -$661K – 550
2016
Q4 		$661K Sell
54,600
-1,100
-2% -$11.5K 0.04% 369
2016
Q3 		$548K Buy
+55,700
New +$508K 0.03% 364
2015
Q3 		– Sell
-10,632
Closed -$255K – 1664
2015
Q2 		$255K Buy
+10,632
New +$205K 0.01% 1177
2014
Q4 		– Sell
-21,620
Closed -$586K – 1194
2014
Q3 		$586K Buy
+21,620
New +$672K 0.01% 893

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PDT Partners's EPZM Position: Q1 2022 in Review

PDT Partners sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 31,115 shares — an estimated $78K sold.

PDT Partners first reported a position in EPZM in Q3 2014 and held it in 20 quarters. The position peaked at $2.79M in Q1 2018. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • PDT Partners reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 31,115 Epizyme, Inc shares in Q1 2022, an estimated $78K.
  • PDT Partners first reported a position in Epizyme, Inc in Q3 2014 and held it in 20 quarters.
  • PDT Partners's Epizyme, Inc position peaked at $2.79M in Q1 2018.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.